Hims & Hers Health, Inc. (HIMS) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
HIMS currently has 224M outstanding shares. with minimal authorized share overhang for future dilution. The company has minimally diluted shareholders by 4.81% over the past 2 years.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Nov 17, 2025 |
8-K filing: Hims & Hers Health, Inc. authorized a $250 million share repurchase program and repurchased 1,334,572 shares of its Class A common stock for $55.5 million, fully utilizing its prior repurchase program. ($55.5M proceeds) |
220M | 0 |
| Aug 04, 2025 |
10-Q filing | 224.4M shares outstanding |
220M | 0 |
| May 05, 2025 |
10-Q filing | 222.0M shares outstanding |
220M | 0 |
| Feb 24, 2025 |
10-K filing | 215.9M shares outstanding |
220M | 0 |
| Nov 04, 2024 |
10-Q filing | 216.6M shares outstanding |
220M | 0 |
| Sep 09, 2024 |
8-K filing: Hims& Hers Health, Inc. registered 976,341 shares of its Class A common stock for resale, issued to Nivagen Pharmaceuticals, Inc. in connection with the Medisource Acquisition, which closed on September 5, 2024. |
210M | 0 |
| Aug 05, 2024 |
10-Q filing | 214.6M shares outstanding |
210M | 0 |
| May 06, 2024 |
10-Q filing | 213.5M shares outstanding |
210M | 0 |
| Feb 26, 2024 |
10-K filing | 209.3M shares outstanding |
210M | 0 |
| Nov 06, 2023 |
10-Q filing | 210.1M shares outstanding |
210M | 0 |
| Aug 07, 2023 |
10-Q filing | 208.4M shares outstanding |
210M | 0 |
| May 08, 2023 |
10-Q filing | 207.1M shares outstanding |
210M | 0 |
| Feb 27, 2023 |
10-K filing | 204.5M shares outstanding |
200M | 0 |
| Nov 07, 2022 |
10-Q filing | 205.2M shares outstanding |
210M | 0 |
| Aug 08, 2022 |
10-Q filing | 203.9M shares outstanding |
200M | 0 |
| May 09, 2022 |
10-Q filing | 202.7M shares outstanding |
200M | 0 |
| Feb 24, 2022 |
10-K filing | 186.8M shares outstanding |
190M | 0 |
| Feb 04, 2022 |
POS AM filing: This is a POS AM filing for the resale of Class A common stock by selling securityholders. |
200M | 0 |
| Nov 10, 2021 |
10-Q filing | 200.0M shares outstanding |
200M | 0 |
| Aug 11, 2021 |
10-Q filing | 191.9M shares outstanding |
190M | 0 |
| May 17, 2021 |
10-Q filing | 183.4M shares outstanding |
180M | 0 |
| Mar 22, 2021 |
10-K filing | 4.3M shares outstanding |
4.3M | 0 |
| Feb 11, 2021 |
S-1/A filing: This is an S-1/A filing related to the registration of Class A common stock issued or issuable under equity compensation plans. |
4.3M | 0 |
| Feb 05, 2021 |
S-1 filing: This is an S-1 filing that discusses the offering of Class A common stock underlying warrants with an exercise price of $11.50 per share. It also mentions the trading symbols for the Class A common stock and public warrants on the NYSE. |
4.3M | 0 |
| Nov 13, 2020 |
10-Q filing | 4.3M shares outstanding |
4.3M | 0 |
| Aug 13, 2020 |
10-Q filing | 20.1M shares outstanding |
20M | 0 |
| May 14, 2020 |
10-Q filing | 4.3M shares outstanding |
4.3M | 0 |
| Mar 27, 2020 |
10-K filing | 4.3M shares outstanding |
4.3M | 0 |